| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
27,611 |
24,242 |
$2.61M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
21,432 |
17,777 |
$1.97M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
12,879 |
10,376 |
$1.49M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,290 |
2,765 |
$874K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
6,326 |
5,467 |
$765K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,205 |
1,877 |
$582K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,898 |
5,151 |
$566K |
| G0378 |
Hospital observation service, per hour |
10,783 |
4,059 |
$331K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,131 |
3,269 |
$322K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,677 |
4,741 |
$303K |
| 80053 |
Comprehensive metabolic panel |
20,666 |
15,821 |
$238K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
798 |
678 |
$223K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,323 |
3,485 |
$179K |
| 71046 |
Radiologic examination, chest; 2 views |
5,786 |
5,079 |
$160K |
| 76641 |
|
3,752 |
2,249 |
$129K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
943 |
757 |
$122K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
4,697 |
4,326 |
$111K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,416 |
1,262 |
$110K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,652 |
1,510 |
$107K |
| 81001 |
|
15,825 |
13,414 |
$102K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,445 |
5,626 |
$91K |
| 76536 |
|
1,297 |
1,189 |
$82K |
| S0028 |
Injection, famotidine, 20 mg |
2,499 |
1,965 |
$71K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,674 |
3,044 |
$67K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
824 |
691 |
$64K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,370 |
1,270 |
$63K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
864 |
715 |
$59K |
| 76830 |
Ultrasound, transvaginal |
1,321 |
1,231 |
$57K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,371 |
1,213 |
$56K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,227 |
1,805 |
$47K |
| 81025 |
|
10,514 |
9,371 |
$47K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,606 |
4,842 |
$47K |
| 70486 |
|
206 |
184 |
$40K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,624 |
1,369 |
$39K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
319 |
279 |
$37K |
| 77080 |
|
880 |
771 |
$36K |
| 87070 |
|
2,637 |
2,379 |
$35K |
| 71250 |
|
602 |
475 |
$35K |
| 71045 |
Radiologic examination, chest; single view |
9,227 |
7,368 |
$34K |
| 73562 |
|
1,532 |
1,186 |
$34K |
| 72100 |
|
1,310 |
1,149 |
$33K |
| A9270 |
Non-covered item or service |
6,033 |
2,818 |
$32K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
29,501 |
20,210 |
$31K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,131 |
1,708 |
$28K |
| 82962 |
|
6,899 |
2,586 |
$27K |
| 77066 |
Tomosynthesis, mammo |
667 |
576 |
$27K |
| J7050 |
Infusion, normal saline solution, 250 cc |
4,892 |
3,508 |
$26K |
| 87400 |
|
2,632 |
2,154 |
$25K |
| 93971 |
|
1,028 |
832 |
$23K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,554 |
1,417 |
$23K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
11,776 |
9,550 |
$23K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,022 |
5,458 |
$23K |
| 73030 |
|
1,116 |
901 |
$21K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
10,975 |
7,733 |
$21K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
439 |
389 |
$21K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
98 |
37 |
$19K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,707 |
1,341 |
$18K |
| 74018 |
|
619 |
533 |
$18K |
| 77072 |
|
334 |
311 |
$18K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
237 |
189 |
$17K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
935 |
707 |
$17K |
| 73630 |
|
1,043 |
870 |
$17K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
236 |
201 |
$17K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,671 |
7,804 |
$16K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
954 |
733 |
$16K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
626 |
256 |
$16K |
| 77065 |
Tomosynthesis, mammo |
523 |
462 |
$16K |
| J3490 |
Unclassified drugs |
151 |
88 |
$15K |
| 93970 |
|
446 |
366 |
$15K |
| 73610 |
|
662 |
584 |
$15K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,042 |
1,598 |
$14K |
| 76770 |
|
270 |
225 |
$14K |
| 72131 |
|
112 |
92 |
$14K |
| J2704 |
Injection, propofol, 10 mg |
1,821 |
1,452 |
$13K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
118 |
87 |
$12K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
8,341 |
6,132 |
$12K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
4,405 |
3,997 |
$12K |
| 85610 |
|
4,281 |
3,253 |
$12K |
| 73130 |
|
604 |
521 |
$11K |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,409 |
651 |
$10K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
901 |
801 |
$10K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
891 |
736 |
$10K |
| 76775 |
|
169 |
155 |
$10K |
| 72040 |
|
275 |
244 |
$10K |
| 84484 |
|
8,510 |
4,789 |
$10K |
| 73502 |
|
439 |
342 |
$10K |
| 76801 |
|
740 |
653 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
2,212 |
1,112 |
$9K |
| 84702 |
|
1,927 |
1,459 |
$9K |
| 85730 |
|
3,728 |
2,809 |
$9K |
| 85027 |
|
1,060 |
764 |
$8K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,855 |
3,258 |
$7K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,366 |
1,062 |
$7K |
| 83735 |
|
7,953 |
5,638 |
$6K |
| J1815 |
Injection, insulin, per 5 units |
471 |
213 |
$5K |
| 72141 |
|
75 |
65 |
$5K |
| 73110 |
|
286 |
255 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,708 |
1,154 |
$5K |
| 96376 |
|
3,254 |
1,709 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,145 |
1,678 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,450 |
5,411 |
$4K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
349 |
213 |
$4K |
| 84703 |
|
2,321 |
2,031 |
$4K |
| 83880 |
|
2,007 |
1,548 |
$4K |
| 87040 |
|
1,492 |
763 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,133 |
5,164 |
$4K |
| 86885 |
|
1,572 |
1,268 |
$4K |
| 83690 |
|
6,083 |
4,989 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,368 |
1,154 |
$3K |
| 82550 |
|
3,937 |
2,371 |
$3K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
644 |
454 |
$3K |
| 86901 |
|
2,437 |
2,002 |
$3K |
| 80061 |
Lipid panel |
421 |
326 |
$3K |
| 59025 |
Fetal non-stress test |
519 |
382 |
$2K |
| 86900 |
|
1,585 |
1,278 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
58 |
56 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,363 |
1,086 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
483 |
241 |
$2K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,239 |
1,046 |
$2K |
| 87210 |
|
719 |
637 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
831 |
751 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
859 |
679 |
$2K |
| 87430 |
|
2,716 |
2,515 |
$1K |
| 99001 |
|
4,774 |
4,242 |
$1K |
| 87088 |
|
1,371 |
1,139 |
$1K |
| 83605 |
|
1,160 |
742 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
930 |
833 |
$1K |
| 80076 |
|
573 |
489 |
$1K |
| 87186 |
|
1,391 |
1,130 |
$1K |
| 29125 |
|
65 |
56 |
$975.47 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
339 |
267 |
$936.01 |
| C1769 |
Guide wire |
20 |
12 |
$903.76 |
| 76882 |
|
16 |
12 |
$897.52 |
| 84100 |
|
415 |
287 |
$865.00 |
| 82150 |
|
1,286 |
1,068 |
$823.40 |
| 85379 |
|
732 |
643 |
$739.87 |
| 87420 |
|
492 |
474 |
$719.57 |
| 87632 |
|
12 |
12 |
$645.18 |
| 97162 |
|
192 |
133 |
$618.93 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,334 |
1,049 |
$606.07 |
| 93880 |
|
14 |
12 |
$567.73 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
189 |
146 |
$535.09 |
| 76870 |
|
14 |
13 |
$517.10 |
| 97161 |
|
54 |
42 |
$445.56 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
466 |
301 |
$411.86 |
| J2060 |
Injection, lorazepam, 2 mg |
438 |
322 |
$311.93 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
35 |
27 |
$250.44 |
| 88342 |
|
120 |
92 |
$167.15 |
| 10060 |
|
44 |
36 |
$154.94 |
| 73080 |
|
16 |
12 |
$154.87 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
99 |
84 |
$148.68 |
| 87077 |
|
882 |
724 |
$121.81 |
| 81003 |
|
19 |
15 |
$120.00 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
16 |
12 |
$86.98 |
| 73140 |
|
26 |
25 |
$62.20 |
| 90715 |
|
220 |
198 |
$61.15 |
| 86140 |
|
85 |
67 |
$6.61 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
414 |
364 |
$4.64 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
171 |
127 |
$0.00 |
| 85651 |
|
155 |
127 |
$0.00 |
| A4217 |
Sterile water/saline, 500 ml |
78 |
60 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
59 |
55 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
46 |
38 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
15 |
12 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
36 |
31 |
$0.00 |
| 88307 |
|
15 |
13 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
38 |
25 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
18 |
12 |
$0.00 |
| 74022 |
|
15 |
15 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
72 |
50 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
18 |
16 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
14 |
12 |
$0.00 |
| 97116 |
|
30 |
12 |
$0.00 |
| 99218 |
|
106 |
38 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
18 |
16 |
$0.00 |
| 94664 |
|
162 |
138 |
$0.00 |
| 82947 |
|
15 |
14 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
35 |
29 |
$0.00 |